MOTS-c

N/A

Report date: 2026/04/03 20:03:44
NME

Base Information

Drug NameMOTS-c
Drug Alias NameMitochondrial-Derived Peptide (Hudson Biotech)
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsOverweightObesityInsulin Resistance +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesHudson Biotech
China Registration ClassN/A

Develop Information

Active CompaniesHudson Biotech
Inactive CompaniesN/A
Active IndicationsOverweightObesityInsulin Resistance +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A